Therapeutic potential of a synthetic dual JAK1/TYK2 inhibitor in inflammatory bowel disease
Xue Cui, Yaxin Teng, Yiguo Hu, Qingqing Li, Heying Pei, Zhuang Yang
Topics & Concepts
TofacitinibTyrosine kinase 2Inflammatory bowel diseasePharmacologyMedicineJanus kinaseUlcerative colitisCytokineInternal medicineDiseaseRheumatoid arthritisReceptorPlatelet-derived growth factor receptorGrowth factorCytokine Signaling Pathways and InteractionsInflammatory Bowel Diseaseinterferon and immune responses